-
1
-
-
0028003766
-
Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment
-
Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
-
Connor EM, Sperling RS, Gelber R, et al. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-80.
-
(1994)
N Engl J Med
, vol.331
, pp. 1173-1180
-
-
Connor, E.M.1
Sperling, R.S.2
Gelber, R.3
-
2
-
-
0028765439
-
Recommendations of the US Public Health Service Task Force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus
-
US Public Health Service Task Force. Recommendations of the US Public Health Service Task Force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43:1-20.
-
(1994)
MMWR Morb Mortal Wkly Rep
, vol.43
, pp. 1-20
-
-
-
3
-
-
0003227545
-
Trends in prevention of perinatal HIV transmission, New York State (NYS), 1997-1999
-
Chicago, February 4-8
-
Wade N, Zielinski M, Glaros R, et al. Trends in prevention of perinatal HIV transmission, New York State (NYS), 1997-1999 [abstract 701]. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, February 4-8, 2001.
-
(2001)
8th Conference on Retroviruses and Opportunistic Infections
-
-
Wade, N.1
Zielinski, M.2
Glaros, R.3
-
5
-
-
0034490776
-
Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing
-
Kartsonis NA, D'Aquila RT. Clinical monitoring of HIV-1 infection in the ERA of antiretroviral resistance testing. Infect Dis Clin North Am 2000;14:879-99.
-
(2000)
Infect Dis Clin North Am
, vol.14
, pp. 879-899
-
-
Kartsonis, N.A.1
D'Aquila, R.T.2
-
6
-
-
0032481063
-
Selective vertical transmission of HIV-1 antiretroviral resistance mutations
-
Colgrove RC, Pitt J, Chung PH, et al. Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 1998;12: 2281-8.
-
(1998)
AIDS
, vol.12
, pp. 2281-2288
-
-
Colgrove, R.C.1
Pitt, J.2
Chung, P.H.3
-
7
-
-
0034105783
-
HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study
-
The Women and Infants Transmission Study Group
-
Welles SL, Pitt J, Colgrove R, et al. HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group. AIDS 2000;14:263-71.
-
(2000)
AIDS
, vol.14
, pp. 263-271
-
-
Welles, S.L.1
Pitt, J.2
Colgrove, R.3
-
8
-
-
0028318739
-
HIV-1 reverse transcriptase codon 215 mutation and clinical outcome in children treated with zidovudine
-
Principi N, Marchisio P, De Pasquale MP, et al. HIV-1 reverse transcriptase codon 215 mutation and clinical outcome in children treated with zidovudine. AIDS Res Hum Retroviruses 1994;10: 721-6.
-
(1994)
AIDS Res Hum Retroviruses
, vol.10
, pp. 721-726
-
-
Principi, N.1
Marchisio, P.2
De Pasquale, M.P.3
-
9
-
-
0035877141
-
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)
-
Eshleman SH, Krogstad P, Jackson JB, et al. Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). J Infect Dis 2001;183:1732-8.
-
(2001)
J Infect Dis
, vol.183
, pp. 1732-1738
-
-
Eshleman, S.H.1
Krogstad, P.2
Jackson, J.B.3
-
10
-
-
0035810613
-
Is transmitted drug resistance in HIV on the rise? It seems so
-
Little SJ. Is transmitted drug resistance in HIV on the rise? It seems so. BMJ 2001;322:1074-5.
-
(2001)
BMJ
, vol.322
, pp. 1074-1075
-
-
Little, S.J.1
-
11
-
-
18844469198
-
Vertical transmission of HIV in New York State: A basis for statewide testing of newborns
-
Charbonneau TT, Wade NA, Weiner L, et al. Vertical transmission of HIV in New York State: a basis for statewide testing of newborns. AIDS Patient Care STDS 1997;11:227-36.
-
(1997)
AIDS Patient Care STDS
, vol.11
, pp. 227-236
-
-
Charbonneau, T.T.1
Wade, N.A.2
Weiner, L.3
-
12
-
-
0035173377
-
Human immunodeficiency virus reverse transcriptase and protease sequence database: An expanded data model integrating natural language text and sequence analysis programs
-
Kantor R, Machekano R, Gonzales MJ, et al. Human immunodeficiency virus reverse transcriptase and protease sequence database: an expanded data model integrating natural language text and sequence analysis programs. Nucleic Acids Res 2001;29:296-9.
-
(2001)
Nucleic Acids Res
, vol.29
, pp. 296-299
-
-
Kantor, R.1
Machekano, R.2
Gonzales, M.J.3
-
13
-
-
0012376070
-
Comparison of HIV-1 proviral DNA and plasma RNA genotyping and its utility in the selection of antiretroviral therapy in children
-
Chicago, February 4-8
-
Cooper ER, Christiansen D, Lloyd RM, et al. Comparison of HIV-1 proviral DNA and plasma RNA genotyping and its utility in the selection of antiretroviral therapy in children. 8th Conference on Retroviruses and Opportunistic Infections. Chicago, February 4-8, 2001.
-
(2001)
8th Conference on Retroviruses and Opportunistic Infections
-
-
Cooper, E.R.1
Christiansen, D.2
Lloyd, R.M.3
-
14
-
-
0035371314
-
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant
-
Johnson VA, Petropoulos CJ, Woods CR, et al. Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant. J Infect Dis 2001; 183:1688-93.
-
(2001)
J Infect Dis
, vol.183
, pp. 1688-1693
-
-
Johnson, V.A.1
Petropoulos, C.J.2
Woods, C.R.3
-
15
-
-
0036603048
-
Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of anti-retroviral resistance
-
Nolan M, Fowler MG, Mofenson LM. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of anti-retroviral resistance. J Acquir Immune Defic Syndr 2002;30: 216-29.
-
(2002)
J Acquir Immune Defic Syndr
, vol.30
, pp. 216-229
-
-
Nolan, M.1
Fowler, M.G.2
Mofenson, L.M.3
-
16
-
-
0031912007
-
Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076
-
Eastman PS, Shapiro DE, Coombs RW, et al. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076. J Infect Dis 1998;177:557-64.
-
(1998)
J Infect Dis
, vol.177
, pp. 557-564
-
-
Eastman, P.S.1
Shapiro, D.E.2
Coombs, R.W.3
-
17
-
-
0035364913
-
Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort
-
Masquelier B, Chaix ML, Burgard M, et al. Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort. J Acquir Immune Defic Syndr 2001;27:99-104.
-
(2001)
J Acquir Immune Defic Syndr
, vol.27
, pp. 99-104
-
-
Masquelier, B.1
Chaix, M.L.2
Burgard, M.3
-
18
-
-
0035500336
-
Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: Vertical transmission and clades
-
Palumbo P, Holland B, Dobbs T, et al. Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades. J Infect Dis 2001;184:1120-6.
-
(2001)
J Infect Dis
, vol.184
, pp. 1120-1126
-
-
Palumbo, P.1
Holland, B.2
Dobbs, T.3
-
19
-
-
0035946701
-
Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1
-
Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001;285:2083-93.
-
(2001)
JAMA
, vol.285
, pp. 2083-2093
-
-
Mandelbrot, L.1
Landreau-Mascaro, A.2
Rekacewicz, C.3
-
20
-
-
0035887629
-
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy
-
Perno CF, Cozzi-Lepri A, Balotta C, et al. Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis 2001;184:983-91.
-
(2001)
J Infect Dis
, vol.184
, pp. 983-991
-
-
Perno, C.F.1
Cozzi-Lepri, A.2
Balotta, C.3
-
21
-
-
0003249089
-
Antiretroviral drug susceptibility and response to initial therapy among recently HIV-infected subjects in North America
-
Chicago, February 4-8
-
Little SJ, Routy JP, Daar ES, et al. Antiretroviral drug susceptibility and response to initial therapy among recently HIV-infected subjects in North America. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, February 4-8, 2001.
-
(2001)
8th Conference on Retroviruses and Opportunistic Infections
-
-
Little, S.J.1
Routy, J.P.2
Daar, E.S.3
-
22
-
-
0035810577
-
Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom
-
UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 2001;322: 1087-8.
-
(2001)
BMJ
, vol.322
, pp. 1087-1088
-
-
-
23
-
-
0343183245
-
Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA panel
-
Hirsch MS, Brun-Vezinet F, D'Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA panel. JAMA 2000;283: 2417-26.
-
(2000)
JAMA
, vol.283
, pp. 2417-2426
-
-
Hirsch, M.S.1
Brun-Vezinet, F.2
D'Aquila, R.T.3
-
24
-
-
0032540034
-
Guidelines for the use of antiretroviral agents in pediatric HIV infection
-
Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep 1998;47:1-43.
-
(1998)
MMWR Morb Mortal Wkly Rep
, vol.47
, pp. 1-43
-
-
-
25
-
-
0035146527
-
Structured treatment interruptions in antiretroviral management of HIV - 1
-
Miller V. Structured treatment interruptions in antiretroviral management of HIV - 1. Curr Opin Infect Dis 2001;14:29-37.
-
(2001)
Curr Opin Infect Dis
, vol.14
, pp. 29-37
-
-
Miller, V.1
-
26
-
-
0031661778
-
Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1
-
Pasquier C, Cayrou C, Blancher A, et al. Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1. J Virol 1998;72:8493-501.
-
(1998)
J Virol
, vol.72
, pp. 8493-8501
-
-
Pasquier, C.1
Cayrou, C.2
Blancher, A.3
-
27
-
-
0035121355
-
Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum
-
Dickover RE, Garratty EM, Plaeger S, et al. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001;75: 2194-203.
-
(2001)
J Virol
, vol.75
, pp. 2194-2203
-
-
Dickover, R.E.1
Garratty, E.M.2
Plaeger, S.3
-
28
-
-
0033547422
-
Mother-to-infant transmission of the human immunodeficiency virus during primary infection
-
Van Tine BA, Shaw GM, Aldrovandi G. Mother-to-infant transmission of the human immunodeficiency virus during primary infection. N Engl J Med 1999;341:1548.
-
(1999)
N Engl J Med
, vol.341
, pp. 1548
-
-
Van Tine, B.A.1
Shaw, G.M.2
Aldrovandi, G.3
|